CPT® Code 88385

Deleted

1. Indications

The procedure associated with CPT® Code 88385 is indicated for the evaluation of genetic material using a specific range of molecular probes. The following conditions may warrant the use of this procedure:

• Genetic Testing Evaluation of genetic disorders or predispositions through the analysis of nucleic acid sequences.
• Oncology Assessment of tumor samples for specific genetic markers that may influence treatment decisions.
• Infectious Diseases Detection of pathogens through the identification of their genetic material.

2. Procedure

The procedure for CPT® Code 88385 involves several key steps that ensure accurate evaluation of the nucleic acid molecules using multiple molecular probes. Each step is critical to the overall success of the evaluation:

• Step 1: Sample Preparation The first step involves the collection and preparation of the biological sample, which may include tissue, blood, or other bodily fluids. The sample is processed to extract nucleic acids, ensuring that the material is suitable for analysis.
• Step 2: Probe Selection In this step, a specific set of molecular probes, ranging from 51 to 250, is selected based on the genetic sequences of interest. These probes are designed to bind to complementary nucleic acid sequences within the sample, allowing for targeted analysis.
• Step 3: Array Hybridization The prepared sample is then subjected to array hybridization, where the selected probes are applied to the sample. This process facilitates the binding of probes to their respective target sequences, enabling the detection of specific genetic information.
• Step 4: Data Analysis Following hybridization, the array is analyzed using specialized instruments that detect the binding events. The data generated is then interpreted to identify the presence or absence of specific genetic markers, providing insights into the genetic characteristics of the sample.

3. Post-Procedure

After the completion of the procedure associated with CPT® Code 88385, post-procedure care typically involves the analysis and interpretation of the results obtained from the array evaluation. Healthcare professionals will review the findings to determine any necessary follow-up actions or additional testing that may be required. Patients may receive counseling regarding the implications of the results, especially if genetic predispositions or markers for diseases are identified. It is essential to ensure that proper documentation is maintained for compliance and billing purposes, reflecting the details of the procedure and the findings.